User profiles for O. Sibila

Oriol Sibila

Hospital Clinic - IDIBAPS
Verified email at clinic.cat
Cited by 6439

The microbiome in respiratory medicine: current challenges and future perspectives

R Faner, O Sibila, A Agustí… - European …, 2017 - Eur Respiratory Soc
The healthy lung has previously been considered to be a sterile organ because standard
microbiological culture techniques consistently yield negative results. However, culture-…

The respiratory threat posed by multidrug resistant G ram‐negative bacteria

A Rodrigo‐Troyano, O Sibila - Respirology, 2017 - Wiley Online Library
Respiratory infections are a major cause of global mortality and morbidity. In recent years,
an increased incidence of multidrug‐resistant ( MDR ) Gram‐negative bacteria ( GNB ) has …

[HTML][HTML] Pneumonia in patients with chronic obstructive pulmonary disease

MI Restrepo, O Sibila, A Anzueto - Tuberculosis and respiratory …, 2018 - ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is a frequent comorbid condition associated
with increased morbidity and mortality. Pneumonia is the most common infectious disease …

[HTML][HTML] Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

DMG Halpin, R Faner, O Sibila, JR Badia… - The Lancet Respiratory …, 2020 - thelancet.com
East respiratory syndrome (MERS), were associated with similar clinical features and
outcomes. 2 One might anticipate that patients with chronic respiratory diseases, particularly …

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized …

A Torres, O Sibila, M Ferrer, E Polverino, R Menendez… - Jama, 2015 - jamanetwork.com
… treatment failure was defined as radiographic progression (increase of ≥50% of pulmonary
infiltrates compared with baseline), persistence of severe respiratory failure (ratio of Pao 2 to …

The first tissue-engineered airway transplantation: 5-year follow-up results

…, C Comin, F Lavorini, G ni Fontana, O Sibila… - The Lancet, 2014 - thelancet.com
Background In 2008, the first transplantation of a tissue-engineered trachea in a human
being was done to replace an end-staged left main bronchus with malacia in a 30-year-old …

Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis

…, KL Moffitt, G Suarez-Cuartin, O Sibila… - American journal of …, 2017 - atsjournals.org
Rationale: Sputum neutrophil elastase and serum desmosine, which is a linked marker of
endogenous elastin degradation, are possible biomarkers of disease severity and progression …

[HTML][HTML] Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis

…, F Blasi, O Sibila, AE O'Donnell… - … England Journal of …, 2020 - Mass Medical Soc
Background Patients with bronchiectasis have frequent exacerbations that are thought to be
related to neutrophilic inflammation. The activity and quantity of neutrophil serine proteases, …

[HTML][HTML] Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease

…, AJ Cassidy, G Suarez-Cuartin, O Sibila… - Journal of Allergy and …, 2018 - Elsevier
Background Neutrophil extracellular traps (NETs) have been observed in the airway in
patients with chronic obstructive pulmonary disease (COPD), but their clinical and …

Characterization of eosinophilic bronchiectasis: a European multicohort study

…, MR Loebinger, F Blasi, T Welte, O Sibila… - American journal of …, 2022 - atsjournals.org
Rationale: Bronchiectasis is classically considered a neutrophilic disorder, but eosinophilic
subtypes have recently been described. Objectives: To use multiple datasets available …